SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
195.00    10.00 (5.41%)
Bid:
190.00
Ask:
200.00
Spread: 10.00 (5.263%)
Market Cap: £113.24m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Trading Update

20 Mar 2025 07:00

RNS Number : 3605B
Focusrite PLC
20 March 2025
 

Strictly embargoed for 07.00, 20 March 2025

Focusrite plc

("Focusrite" or "the Group")

Trading Update

Focusrite plc (AIM: TUNE), the global music and audio products group supplying hardware and software used by professional and amateur musicians and the entertainment industry, provides the following update on trading for the six months ended 28 February 2025 ("HY25").

The Group's performance for the period was in line with expectations1. Revenue for the first half is expected to be not less than £80 million, compared with £76.9 million in the first six months of the prior year. On an underlying basis, eliminating the revenue benefit of the planned increase in stock in the US sales channel to mitigate potential tariffs, the Content Creation division grew c.5% in the first half. This growth was partially offset by a decrease of approximately 6% in Audio Reproduction, reflecting the previously highlighted ongoing market realignment following the one off post-COVID boost and a particularly strong comparator in H1 of FY24. The Audio Reproduction division continues to have a stable sales pipeline and, with a seasonal weighting to the second half, revenue is expected to improve in the second six months of this period across this division.

Whilst gross margins have compressed slightly in HY25 due to ongoing elevated freight costs and product mix, planned pricing adjustments and new product introductions are expected to deliver improvements in the remainder of the current period. Price increases relating to US tariffs have been communicated to our customers, effective from 1 May 2025. Overheads have increased in line with expectations, due largely to the resetting of variable remuneration levels as compared to the prior year.

Net debt stands at approximately £18 million as at 28 February 2025 (31 August 2024: net debt of £12.5 million), reflecting the payment of the final dividend and an increase in stock and working capital in anticipation of the expected US tariffs. Net debt levels are expected to improve in the second six months of the current period with an overall cash inflow for the 12 months as a whole. The Group continues to maintain a disciplined approach to capital allocation with £50 million of committed credit facilities ensuring flexibility to support strategic initiatives and future growth opportunities.

Against a background of a normalising market in Content Creation, after an extended period of volatility in the sales channel, Focusrite continues to maintain its leading market position, supported by continuing robust underlying end-user registrations. While broader economic conditions remain fluid, the Group has plans in place to navigate potential challenges and the Board's expectations 1 for the first twelve months of the current eighteen-month period remain unchanged. However, as previously highlighted, H1 EBITDA will be lower than the prior year, and more heavily weighted to the second six months of this period.

The Group looks forward to providing a more detailed trading review when it announces its half year results in late April 2024.

 1 Market expectations are understood to be a range for EBITDA for the 12 months to 31 August 2025 of between £24.5 million and £26.0 million.

- Ends -

Enquiries:

 

Focusrite plc

+44 (0) 1494 462246

Tim Carroll (CEO) / Sally McKone (CFO)

 

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin / Nick Prowting / James Smith

 

Rosewood (Financial PR)

 +44 (0) 20 7653 8702

John West / Llewellyn Angus / Lily Pearce

 

 

 

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under thirteen established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research Sequential, Oberheim, Sonnox, OutBoard and TiMax.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesizers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high-quality, award-winning audio processing software plug-ins for professional audio engineers. TiMax specialises in innovative immersive audio and show control technologies. OutBoard manufactures and sells industry standard rigging control products for live events, together with enterprise-level safety test, preparation and quality management for global rental companies and venues.

The Company has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGMFVLZGKZM
Date   Source Headline
14th Dec 201810:14 amRNSDirectors' Dealings
4th Dec 20187:00 amRNSExercise of Share Options
3rd Dec 20183:12 pmRNSExercise of Share Options by a PDMR
26th Nov 20183:36 pmRNSGrant of Share Options to Directors
23rd Nov 201812:34 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:29 pmRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSFinal Results for the Year Ended 31 August 2018
8th Nov 20184:12 pmRNSHolding(s) in Company
18th Sep 20187:00 amRNSTrading Update
27th Jul 20189:45 amRNSTR-1
3rd Jul 201810:53 amRNSTR-1
29th May 20187:00 amRNSAppointment of Non-executive director
18th May 20185:06 pmRNSHolding(s) in Company
8th May 20189:31 amRNSDirector/PDMR Shareholding
3rd May 201812:18 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSHalf Year Results
9th Mar 20183:45 pmRNSDirector/PDMR Shareholding
9th Mar 20187:00 amRNSTrading Update
29th Jan 20183:38 pmRNSTR-1
29th Jan 201811:27 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 20183:02 pmRNSResult of 2018 AGM
10th Jan 20187:00 amRNSAGM Statement and Update on Trading
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
15th Dec 20174:02 pmRNSDirector's Dealings
14th Dec 20179:56 amRNSDirector/PDMR Shareholding
5th Dec 201712:56 pmRNSTR-1: Standard form
30th Nov 20176:14 pmRNSCompletion of Secondary Placing of Shares
30th Nov 20174:35 pmRNSProposed Secondary Placing of Shares
24th Nov 20174:24 pmRNSPDMR Shareholding
23rd Nov 201710:22 amRNSPDMR Grant of Share Options
23rd Nov 201710:21 amRNSDirector's Dealings
23rd Nov 20177:00 amRNSDirector Share Dealings - Replacement
22nd Nov 20172:50 pmRNSDirector Share Dealings
21st Nov 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
20th Sep 20172:54 pmRNSHolding(s) in Company
13th Sep 20177:00 amRNSTrading Update
31st Aug 20177:00 amRNSTR-1: Notification of major holdings
19th May 20173:40 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSHalf Year Results for the period ended 28 Feb 2017
20th Mar 20177:00 amRNSTrading Update
24th Feb 20173:56 pmRNSPDMR Grant of Share Options
10th Jan 20172:46 pmRNSResult of AGM
10th Jan 20177:00 amRNSAGM Statement
7th Dec 20164:28 pmRNSTR-1: Notification of Major Interest in Shares
6th Dec 201611:00 amRNSAnalyst and Investor Day
5th Dec 20163:13 pmRNSDirector/PDMR Shareholding
5th Dec 20167:00 amRNSAppointment of Chief Executive Officer
24th Nov 20165:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.